NUHBC presents Dr. Lou DeGenarro, the CEO of the Leukemia and Lymphoma society, which is one of the largest charities in the world.
Make sure you join us on October 11, 2018 starting at 6:00PM in 106 West Village G to learn more about Dr. DeGenarro’s experiences in research, education, and pharmaceutical development.
About Dr. Lou Degenarro
Dr. Lou Degenarro has been the CEO of the Leukemia and Lymphoma society since 2014, and has dedicated his career to saving lives through drug discovery. DeGenarro receiving his doctorate in biochemistry from the University of California at San Francisco, and completed his post-doctoral research at the Yale University School of Medicine. His previous academic appointments include research group leader at Max Planck Institute in Munich, Germany, where his laboratory was among the first to clone genes expressed exclusively in the nervous system; and associate professor of neurology and cell biology, University of Massachusetts Medical School.
About the Leukemia and Lymphoma Society
The Leukemia and Lymphoma Society is devoted to ultimately discovering the cure for leukemia, lymphoma, Hodgkin’s disease and myeloma while also improving patient care. The nonprofit organization is one of the biggest contributors to blood cancer research, and through its vast network of volunteers, the organization advocates for greater federal funding for cancer research. The Leukemia and Lymphoma Society is also a strong advocate for greater access of healthcare for cancer patients, and the organization seeks to provide information and remove barriers in regards to cancer treatment.